|
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression
|
5R01CA131914-02
|
$233,704
|
$233,704
|
LI, XIAOTAO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$287,498
|
$11,500
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Research in Cancer
|
3P30CA056036-10S1
|
$63,390
|
$1,268
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-10S2
|
$98,650
|
$1,973
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-10
|
$3,102,433
|
$62,049
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transcriptional Repression of Sodium-Iodide Symporter in Thyroid Carcinoma
|
5R01CA125166-02
|
$126,000
|
$126,000
|
Ain, Kenneth
|
UNIVERSITY OF KENTUCKY
|
|
Tilting the balance in cancer immunotherapy and autoimmunity
|
5R01CA125680-04
|
$259,391
|
$85,599
|
Wei, Wei-Zen
|
WAYNE STATE UNIVERSITY
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$447,218
|
$447,218
|
Kimura, Shioko
|
CCR (NCI)
|
|
Thiazolidinediones as Thyroid Cancer Therapy
|
5R01CA100560-05
|
$284,732
|
$284,732
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
The Role of Fragile Sites in RET/PTC Rearrangement
|
5R01CA113863-04
|
$257,850
|
$257,850
|
WANG, YUH-HWA
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S1
|
$89,606
|
$6,272
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-34
|
$3,956,712
|
$276,970
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Chernobyl Tissue Bank
|
5U24CA082102-09
|
$309,715
|
$309,715
|
Thomas, Geraldine
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
Study to improve thyroid doses from fallout exposure in Kazakhstan
|
ZIA CP010132-10395
|
$302,600
|
$302,600
|
Mabuchi
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04020
|
$2,310
|
$115
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04033
|
$172,949
|
$17,295
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04150
|
$62,859
|
$1,886
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04175
|
$30,597
|
$12,239
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10430
|
$103,605
|
$103,605
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10441
|
$63,699
|
$12,740
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Atomic Bomb Survivors
|
ZIA CP010134-04016
|
$480,282
|
$24,014
|
Mabuchi, Kiyohitko
|
DCEG (NCI)
|
|
Signaling Pathways in Proliferation and Differentiation
|
5R01CA065842-15
|
$423,810
|
$423,810
|
EWEN, MARK
|
DANA-FARBER CANCER INSTITUTE
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123-02342
|
$684,129
|
$34,206
|
Chow
|
DCEG (NCI)
|
|
Role of Skp2-cyclin A Interaction in Normal Physiology and Cancer
|
1R01CA131421-01A2
|
$310,005
|
$155,003
|
ZHU, LIANG
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010136-10447
|
$50,433
|
$50,433
|
Berrington
|
DCEG (NCI)
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
$6,580
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Regional Oncology Research Center
|
3P30CA006973-47S1
|
$126,362
|
$3,791
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-47S2
|
$250,000
|
$7,500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-47S3
|
$100,000
|
$3,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-47
|
$7,507,885
|
$225,237
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Rap1Gap and Tumor Progression
|
1R01CA127986-01A2
|
$329,925
|
$329,925
|
MEINKOTH, JUDY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Radiation-induced Thyroid Cancer
|
1R01CA136685-01A1
|
$383,098
|
$383,098
|
WEIER, HEINZ-ULRICH
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$774,176
|
$38,709
|
Alavanja
|
DCEG (NCI)
|
|
Prospective Studies of Diet and Cancer in the AARP Cohort
|
ZIA CP010196-03152
|
$1,665,672
|
$83,284
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
Preoperative and follow-up tests for thyroid tumors
|
4R33CA113461-02
|
$277,131
|
$277,131
|
RIGGINS, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
|
Prediction of Second Cancer Risks for Children Treated with Proton - vs. - Photon
|
5R01CA131463-02
|
$255,640
|
$38,346
|
Newhauser, Wayne
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$532,506
|
$426,005
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
Oncogenic Events in Thyroid Neoplasia
|
5R01CA072597-13
|
$459,333
|
$459,333
|
FAGIN, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
NEW DIRECTIONS IN THYROID CANCER RESEARCH AND TREATMENT
|
5R13CA132472-03
|
$7,500
|
$7,500
|
MOLEY, JEFFREY
|
WASHINGTON UNIVERSITY
|
|
Molecular Pathophysiology of Thyroid Cell Growth
|
5R01CA050706-20
|
$390,958
|
$390,958
|
FAGIN, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Molecular Events in the PI3K/Akt Pathway in Thyroid Cancer
|
1R01CA134225-01A2
|
$332,332
|
$332,332
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Molecular Classification of Suspicious Thyroid Tumors
|
5R01CA107247-05
|
$307,116
|
$307,116
|
ZEIGER, MARTHA
|
JOHNS HOPKINS UNIVERSITY
|
|
Modelling BRaf-dependent thyroid cancer in the mouse
|
1F32CA142150-01
|
$59,402
|
$59,402
|
McFadden, David
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,416,561
|
$220,828
|
Fojo, Antonio
|
CCR (NCI)
|
|
Mechanisms of RET/PTC Rearrangement in Thyroid Cancer
|
5R01CA088041-08
|
$234,137
|
$234,137
|
NIKIFOROV, YURI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Isozyme specific effects of PKCs in thyroid cells
|
5R01CA109543-05
|
$231,880
|
$231,880
|
MEINKOTH, JUDY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Improving thyroid cancer management using high-frequency quantitative ultrasound
|
1R21CA139095-01
|
$194,005
|
$194,005
|
Oelze, Michael
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
GSK3-beta Signaling in Medullary Thyroid Cancer
|
1R01CA121115-01A2
|
$279,819
|
$279,819
|
CHEN, HERBERT
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
|
5P01CA124570-02
|
$2,398,547
|
$2,398,547
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
Genetic and Epigenetic Events in Papillary Thyroid Cancer
|
5R01CA113507-04
|
$282,659
|
$282,659
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Thyroid for this search: $14,734,348
|